posts category

Macrogen News

CRISPR-Cas9 commercial research tool technology acquired from Broad Institute will be used to build preclinical model animals and target treatment function analysis to further gene treatment research and development Macrogen, Inc. (CEO Ji-young Moon, www.macrogen.com), a precision medicine biotechnology company, announced on April 5 that it …

Continue reading

The unique genetic diversity that is prevalent in South, North, and East Asia provides a valuable source for clinical insights that will be able to enhance the understanding of disease biology. In order to help accelerate population specific precision medicine, Macrogen got involved with Genome Asia 100K in 2016, and …

Continue reading

  What does it mean to map the human genome? Humans may be 99.9 per cent similar to one another, yet the miniscule remaining percentage spells all the difference – making one drug effective for one patient and life-threatening for another. Having a map of one’s genome means …

Continue reading

– Establishment of Genome Sequencing Industry’s First Branch in Spain, Strengthening Localization Service in Southern Europe and MENA SEOUL, South Korea– Macrogen inc. (CEO Hyon Yong Chong, www.macrogen.com) (KOSDAQ:038290), a precision medicine biotechnology company, announced on Sep 4 that it will begin providing localization service …

Continue reading
Continue reading